MERCK FOUNDATION at African Union Assembly, African First Ladies Summit

image

Guest of honour, Prof. Frank Stangenberg-Haverkamp affirms Merck's long term partnership with African countries 

Watch video below


Prof. Frank Stangenberg-Haverkamp-Merck Foundation at African First Ladies Summit, AU Assembly

Merck Foundation continues its strong partnership with African Countries, to build healthcare capacity, improve access to cancer care and advance people lives through science and technology.

During The 19th General Assembly of the Organization of First Ladies of Africa (OAFLA), held at the African Union. Guest of honour, Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KGandChairman of Board of Trustees of Merck Foundation and Dr Rasha Kelej, CEO of Merck Foundation, affirmed Merck’s long term partnership with African countriesto provide oncology fellowship programs, provide practical training for fertility specialists and to empower infertile women through access to information , health and changeof mind-set through “Merck Cancer Access Program” and “Merck More than a Mother” campaign.

Meeting the First Ladies of Africa:
Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG and Chairman of Board of Trustees of Merck Foundation and Dr Rasha Kelej, CEO of Merck Foundation, meet the First Ladies.

 


From left to right: H.E. Roman Tesfaye,The First Lady of; H.E. Rebecca Naa Okaikor Akufo-Addo,The First Lady of Ghana; H.E. Aisha Muhammadu Buhari, The First Lady of Nigeria; Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG  and  Chairman of Board of Trustees of Merck Foundation, Dr Rasha Kelej, CEO of Merck Foundation


H.E Sia Nyama Koroma, The First Lady of Sierra Leone (centre); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG  and  Chairman of Board of Trustees of Merck Foundation (right), Dr Rasha Kelej, CEO of Merck Foundation (left)


H.E. Brigitte Touadera The First Lady of C.A.R. (front right); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KGandChairman of Board of Trustees of Merck Foundation (left), Dr Rasha Kelej, CEO of Merck Foundation (back left)


H.E. Roman Tesfaye The First Lady of Ethiopia (centre); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KGandChairman of Board of Trustees of Merck Foundation (right), Dr Rasha Kelej, CEO of Merck Foundation (left)


H.E. Maria Rosa Teixeira The First Lady of Guinea Bissau (right); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KGandChairman of Board of Trustees of Merck Foundation (back left), Dr Rasha Kelej, CEO of Merck Foundation (left)


H.E. Aisha Muhammadu Buhari The First Lady of Nigeria (left); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KGandChairman of Board of Trustees of Merck Foundation (centre), Dr Rasha Kelej, CEO of Merck Foundation (right)


H.E. Inkhosikati LaMbikiza, The First Lady of Swaziland (front) greets Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG and Chairman of Board of Trustees of Merck Foundation as H.E Sia Nyama Koroma, The First Lady of Sierra Leone (centre back) and Dr Rasha Kelej, CEO of Merck Foundation (left back) look on.


H.E. Hinda Deby Itno, The First Lady of Chad (left) greets H.E Sia Nyama Koroma, The First Lady of Sierra Leone as H.E. Maria Rosa Teixeira, The First Lady of Guinea Bissau (back left), Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG and Chairman of Board of Trustees of Merck Foundation and Dr Rasha Kelej, CEO of Merck Foundation look on.


H.E. Dominique Ouattara, The First Lady of Côte d’Ivoire (left); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG  and  Chairman of Board of Trustees of Merck Foundation (right), Dr Rasha Kelej, CEO of Merck Foundation (centre)


H.E. Mathato S. Mosisili , The First Lady of Lesotho (centre); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG  and  Chairman of Board of Trustees of Merck Foundation (right), Dr Rasha Kelej, CEO of Merck Foundation (left)


H.E. Fatoumatta Bah-Barrow, The First Lady of Gambia (right); Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E. Merck KG  and  Chairman of Board of Trustees of Merck Foundation (left), Dr Rasha Kelej, CEO of Merck Foundation (second left)


19th General Assembly of the Organization of First Ladies of Africa (OAFLA) dignitaries


19th General Assembly of the Organization of First Ladies of Africa (OAFLA), held at the African Union

To learn more about the Merck Foundation programs and their training and fellowship opportunities, please visit their website www.merck-foundation.com and www.merckmorethanamother.com

One Click on icon below to
Download Merck Foundation App


Join the conversation on our social media platforms below and let your voice be heard

 Merck Foundation

 Merck Foundation

 Merck Foundation

 @MerckFoundation

 Merck Foundation

About Merck Foundation

The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website.  Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.